196 related articles for article (PubMed ID: 29906748)
1. Transient receptor potential vanilloid-type 2 targeting on stemness in liver cancer.
Hu Z; Cao X; Fang Y; Liu G; Xie C; Qian K; Lei X; Cao Z; Du H; Cheng X; Xu X
Biomed Pharmacother; 2018 Sep; 105():697-706. PubMed ID: 29906748
[TBL] [Abstract][Full Text] [Related]
2. 8-bromo-7-methoxychrysin suppress stemness of SMMC-7721 cells induced by co-culture of liver cancer stem-like cells with hepatic stellate cells.
Wen Q; Xu C; Zhou J; Liu NM; Cui YH; Quan MF; Cao JG; Ren KQ
BMC Cancer; 2019 Mar; 19(1):224. PubMed ID: 30866863
[TBL] [Abstract][Full Text] [Related]
3. CD133 silencing inhibits stemness properties and enhances chemoradiosensitivity in CD133-positive liver cancer stem cells.
Lan X; Wu YZ; Wang Y; Wu FR; Zang CB; Tang C; Cao S; Li SL
Int J Mol Med; 2013 Feb; 31(2):315-24. PubMed ID: 23233126
[TBL] [Abstract][Full Text] [Related]
4. Esophageal cancer stem cells are suppressed by tranilast, a TRPV2 channel inhibitor.
Shiozaki A; Kudou M; Ichikawa D; Fujiwara H; Shimizu H; Ishimoto T; Arita T; Kosuga T; Konishi H; Komatsu S; Okamoto K; Marunaka Y; Otsuji E
J Gastroenterol; 2018 Feb; 53(2):197-207. PubMed ID: 28389731
[TBL] [Abstract][Full Text] [Related]
5. BORIS up-regulates OCT4 via histone methylation to promote cancer stem cell-like properties in human liver cancer cells.
Liu Q; Chen K; Liu Z; Huang Y; Zhao R; Wei L; Yu X; He J; Liu J; Qi J; Qin Y; Li B
Cancer Lett; 2017 Sep; 403():165-174. PubMed ID: 28645561
[TBL] [Abstract][Full Text] [Related]
6. Defeating EpCAM(+) liver cancer stem cells by targeting chromatin remodeling enzyme CHD4 in human hepatocellular carcinoma.
Nio K; Yamashita T; Okada H; Kondo M; Hayashi T; Hara Y; Nomura Y; Zeng SS; Yoshida M; Hayashi T; Sunagozaka H; Oishi N; Honda M; Kaneko S
J Hepatol; 2015 Nov; 63(5):1164-72. PubMed ID: 26095183
[TBL] [Abstract][Full Text] [Related]
7. High expression of MAGE-A9 contributes to stemness and malignancy of human hepatocellular carcinoma.
Wei Y; Wang Y; Gong J; Rao L; Wu Z; Nie T; Shi D; Zhang L
Int J Oncol; 2018 Jan; 52(1):219-230. PubMed ID: 29138811
[TBL] [Abstract][Full Text] [Related]
8. The transient receptor potential vanilloid-2 cation channel impairs glioblastoma stem-like cell proliferation and promotes differentiation.
Morelli MB; Nabissi M; Amantini C; Farfariello V; Ricci-Vitiani L; di Martino S; Pallini R; Larocca LM; Caprodossi S; Santoni M; De Maria R; Santoni G
Int J Cancer; 2012 Oct; 131(7):E1067-77. PubMed ID: 22492283
[TBL] [Abstract][Full Text] [Related]
9. Positive Feedback Loop of OCT4 and c-JUN Expedites Cancer Stemness in Liver Cancer.
Kuo KK; Lee KT; Chen KK; Yang YH; Lin YC; Tsai MH; Wuputra K; Lee YL; Ku CC; Miyoshi H; Nakamura Y; Saito S; Wu CC; Chai CY; Eckner R; Steve Lin CL; Wang SS; Wu DC; Lin CS; Yokoyama KK
Stem Cells; 2016 Nov; 34(11):2613-2624. PubMed ID: 27341307
[TBL] [Abstract][Full Text] [Related]
10. A Novel Small-molecule WNT Inhibitor, IC-2, Has the Potential to Suppress Liver Cancer Stem Cells.
Seto K; Sakabe T; Itaba N; Azumi J; Oka H; Morimoto M; Umekita Y; Shiota G
Anticancer Res; 2017 Jul; 37(7):3569-3579. PubMed ID: 28668848
[TBL] [Abstract][Full Text] [Related]
11. Sublethal heat treatment of hepatocellular carcinoma promotes intrahepatic metastasis and stemness in a VEGFR1-dependent manner.
Tan L; Chen S; Wei G; Li Y; Liao J; Jin H; Zou Y; Huang M; Peng Z; Guo Y; Peng S; Xu L; Kuang M
Cancer Lett; 2019 Sep; 460():29-40. PubMed ID: 31173855
[TBL] [Abstract][Full Text] [Related]
12. Isovitexin reduces carcinogenicity and stemness in hepatic carcinoma stem-like cells by modulating MnSOD and FoxM1.
Cao X; Liu L; Yuan Q; Li X; Cui Y; Ren K; Zou C; Chen A; Xu C; Qiu Y; Quan M; Zhang J; Cao J; Chen X
J Exp Clin Cancer Res; 2019 Jun; 38(1):264. PubMed ID: 31208440
[TBL] [Abstract][Full Text] [Related]
13. miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1.
Ma S; Tang KH; Chan YP; Lee TK; Kwan PS; Castilho A; Ng I; Man K; Wong N; To KF; Zheng BJ; Lai PB; Lo CM; Chan KW; Guan XY
Cell Stem Cell; 2010 Dec; 7(6):694-707. PubMed ID: 21112564
[TBL] [Abstract][Full Text] [Related]
14. Oxytetracycline have the therapeutic efficiency in CD133
Song Y; Kim IK; Choi I; Kim SH; Seo HR
Sci Rep; 2018 Oct; 8(1):16100. PubMed ID: 30382122
[TBL] [Abstract][Full Text] [Related]
15. Targeting TRPV1 on cellular plasticity regulated by Ovol 2 and Zeb 1 in hepatocellular carcinoma.
Xie C; Liu G; Li M; Fang Y; Qian K; Tang Y; Wu X; Lei X; Li X; Liu Q; Liu G; Liu J; Zhang Y; Huang Z; Hu Z; Cao Z; Hu J; Huang S; Zhong D; Huang J; Wu F; Wang J; Mori M; Yamamoto H; Wang J; Xu X
Biomed Pharmacother; 2019 Oct; 118():109270. PubMed ID: 31401394
[TBL] [Abstract][Full Text] [Related]
16. microRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-Myb.
Zhang J; Luo N; Luo Y; Peng Z; Zhang T; Li S
Int J Oncol; 2012 Mar; 40(3):747-56. PubMed ID: 22025269
[TBL] [Abstract][Full Text] [Related]
17. Silencing PFKP restrains the stemness of hepatocellular carcinoma cells.
Sha X; Wang K; Wang F; Zhang C; Yang L; Zhu X
Exp Cell Res; 2021 Oct; 407(1):112789. PubMed ID: 34418458
[TBL] [Abstract][Full Text] [Related]
18. Smad inhibitor induces CSC differentiation for effective chemosensitization in cyclin D1- and TGF-β/Smad-regulated liver cancer stem cell-like cells.
Xia W; Lo CM; Poon RYC; Cheung TT; Chan ACY; Chen L; Yang S; Tsao GSW; Wang XQ
Oncotarget; 2017 Jun; 8(24):38811-38824. PubMed ID: 28415588
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of transient receptor potential vanilloid 2 expression in human hepatocellular carcinoma.
Liu G; Xie C; Sun F; Xu X; Yang Y; Zhang T; Deng Y; Wang D; Huang Z; Yang L; Huang S; Wang Q; Liu G; Zhong D; Miao X
Cancer Genet Cytogenet; 2010 Feb; 197(1):54-9. PubMed ID: 20113837
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus PreS1 facilitates hepatocellular carcinoma development by promoting appearance and self-renewal of liver cancer stem cells.
Liu Z; Dai X; Wang T; Zhang C; Zhang W; Zhang W; Zhang Q; Wu K; Liu F; Liu Y; Wu J
Cancer Lett; 2017 Aug; 400():149-160. PubMed ID: 28455240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]